Public health relevance of hypertension;Public-health-aspekte der hypertonie: Ein update

Journal fur Hypertonie

Volumn 13, Issue 1, 2009, Pages 7-11

  Dorner, T ^a   Rieder, A ^a  

^a Medical University of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISABILITY ADJUSTED LIFE YEAR; EMPOWERMENT; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MORTALITY; OBESITY; PREVALENCE; PUBLIC HEALTH; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SMOKING; WORLD HEALTH ORGANIZATION;

EID: 63849253875     PISSN: 10282327     EISSN: 16809378     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25: 1751-62.
2. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513-8.
3. WHO (World Health Organisation). The European Health Report 2005. Public health actions for healthier children and populations. WHO Europe, 2005. http:// ww.euro.who.int/document/e87325.pdf [Gesehen 13.1.2009].
4. Schmeiser-Rieder A, Kunze U. Blood pressure awareness in Austria. A 20-year evaluation, 1978-1998. Eur Heart J 2000; 21: 414-20.
5. Prugger C, Wellmann J, Heidrich J, Brand-Herrmann SM, Keil U. Cardiovascular risk factors and mortality in patients with coronary heart disease. Eur J Epidemiol 2008; 23: 731-7.
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
7. Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999; 340: 1221-7.
8. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-9.
9. Fodor JG, Lietava J, Rieder A, Sonkodi S, Stokes H, Emmons T, Turton P. Work-site hypertension prevalence and control in
10. three Central European Countries. J Hum Hypertens 2004; 18: 581-5.
11. Statistik Austria (Hrsg) im Auftrag von Bundesministerium fur Gesundheit, Familie und Jugend. Österreichische Gesundheits-befragung 2006/07. Hauptergebnisse und methodische Dokumentation. Wien, 2007.
12. Oliveria SA, Chen RS, McCarthy BD, Davis CC, Hill MN. Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med 2005; 20: 219-25.
13. Dorner T, Fodor JG, Allichhammer D, Kiefer I, Lawrence K, D'Angelo MS, Huebel U, Strunz B, Ohnoutka A, Antes G, Schmidl H, Kunze M, Rieder A. ["A heart for Vienna"-the prevention program for the big city. Blue-collar workers as a special target group.] Wien Med Wochenschr 2006; 156: 552-7.
14. Schaefer C. Quality of life and self-monitoring: CVD prevention in practice. The role of patient organizations in CVD prevention. Eur Heart J Suppl 2007; 9: B42- B44.
15. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation 2005; 112: 1651.
16. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich) 2000; 2: 324-30.
17. Banegas JR, Segura J, Ruilope LM, Luque M, García-Robles R, Campo C, Rodríguez-Artalejo F, Tamargo J; CLUE Study Group Investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension 2004; 43: 1338-44.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
19. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-86.
20. Joffres MR, Hamet P, MacLean DR, L'italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001; 14: 1099-105.
21. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10-7.
22. Flack JM, Casciano R, Casciano J, Doyle J, Arikian S, Tang S, Arocho R. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface 2002; 15: 28-36.
23. Long G, Cutler DM, Berndt ER. Antihypertensive drugs: a perspective on the value of improved blood pressure control in the USA. Eur Heart J Suppl 2007; 9: B19-B22.
24. Lloyd A, Schmieder C, Marchant N. Financial and health costs of uncontrolled blood pressure in the United Kingdom. Pharmacoeconomics 2003; 21 (Suppl 1): 33-41.
25. Hansson L, Lloyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002; 11: 35-45.
26. Rieder A. Getting into a healthy 'CV success zone': effective strategies to prevent CVD. Eur Heart J Suppl 2007; 9: B4-B7.
27. Vorsorgeuntersuchung Neu http://www.sozialversicherung.at/ mediaDB/MMDB89423-arztmanual-gesamt.pdf [Gelesen 13.1.2009].
28. Wood D. The concept of doctor targets based on quality guidelines: focus on blood pressure. Eur Heart J Suppl 2007; 9: B29-B36.
29. Szirmai LA, Arnold C, Farsang C. Improving control of hypertension by an integrated approach - results of the 'Manage it well!' programme. J Hypertens 2005; 23: 203-11.
30. Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, Wallston KA, Dittus RS, Alvarez V, Cobb J, Speroff T. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med 2006; 145: 165-75.
31. Campbell NR, Petrella R, Kaczorowski J. Public education on hypertension: a new initiative to improve the prevention, treatment and control of hypertension in Canada. Can J Cardiol 2006; 22: 599-603.
32. MacMahon S, Neal B, Rodgers A. Hypertension - time to move on. Lancet 2005; 365: 1108-9.
33. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and anti- hypertensive medications. Circulation 2006; 114: 160-7.
34. He FJ, MacGregor GA. Blood pressure is the most important cause of death and disability in the world. Eur Heart J Suppl 2007; 9: B23-B28.